Alveolar	JJ
epithelial	JJ
cell	NN
injury	NN
with	IN
Epstein-Barr	JJ
virus	NN
upregulates	VBZ
TGFbeta1	NN
expression	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
refractory	JJ
and	CC
lethal	JJ
interstitial	JJ
lung	NN
disease	NN
characterized	VBN
by	IN
alveolar	JJ
epithelial	JJ
cells	NNS
apoptosis	NN
,	,
fibroblast	NN
proliferation	NN
,	,
and	CC
ECM	NN
protein	NN
deposition	NN
.	.

Epstein-Barr	JJ
virus	NN
(	(
EBV	NN
)	)
has	VBZ
previously	RB
been	VBN
localized	JJ
to	TO
alveolar	JJ
epithelial	JJ
cells	NNS
of	IN
IPF	NN
patients	NNS
and	CC
is	VBZ
associated	VBN
with	IN
a	DT
poor	JJ
prognosis	NN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
utilized	VBD
a	DT
microarray-based	JJ
differential	JJ
gene	NN
expression	NN
analysis	NN
strategy	NN
to	TO
identify	VB
molecular	JJ
drivers	NNS
of	IN
EBV-associated	JJ
lung	NN
fibrosis	NN
.	.

Two	CD
cell	NN
lines	NNS
,	,
primary	JJ
human	JJ
alveolar	JJ
epithelial	JJ
cells	NNS
type	NN
2	CD
and	CC
A549	NN
cells	NNS
,	,
were	VBD
infected	VBN
with	IN
EBV	NN
.	.

EBV	NN
lytic	JJ
phase	NN
induction	NN
increased	VBD
active	JJ
and	CC
total	JJ
transforming-growth-factor-beta1	NN
(	(
TGFbeta1	NN
)	)
transcript	NN
expression	NN
in	IN
association	NN
with	IN
reduced	VBN
cell	NN
proliferation	NN
and	CC
increased	VBD
caspase	NN
3/7	CD
activity	NN
.	.

Exposing	VBG
EBV-infected	JJ
cells	NNS
to	TO
ganciclovir	NN
resulted	VBD
in	IN
TGFbeta1	NN
deregulation	NN
and	CC
reduced	VBN
expression	NN
of	IN
EBV	NN
early	JJ
response	NN
genes	NNS
,	,
BRLF1	NN
and	CC
BZLF1	NN
.	.

We	PRP
targeted	VBD
the	DT
BRLF1	NN
and	CC
BZLF1	NN
gene	NN
products	NNS
,	,
Rta	NN
and	CC
Zta	NN
,	,
by	IN
silencing	NN
RNA	NN
,	,
and	CC
this	DT
resulted	VBD
in	IN
the	DT
normalization	NN
of	IN
TGFbeta1	NN
transcript	NN
and	CC
cell	NN
proliferation	NN
levels	NNS
.	.

Our	PRP$
study	NN
using	VBG
a	DT
viral	JJ
cell	NN
line	NN
model	NN
complements	VBZ
existing	VBG
human	JJ
and	CC
animal	JJ
model	NN
data	NNS
and	CC
further	JJ
provides	VBZ
evidence	NN
to	TO
suggest	VB
that	IN
viral	JJ
epithelial	JJ
cell	NN
injury	NN
may	MD
play	VB
a	DT
role	NN
in	IN
IPF	NN
.	.

